NANCY SMITH: Open Payments
NPI 1326338542 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,097 in 135 payments from 19 companies in 2025. Trend: 2023 $1,952 · 2024 $2,004 · 2025 $3,097
Food & beverage: $3,022Education: $75
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 15 | $648 |
| Janssen Biotech, Inc. | 19 | $437 |
| UCB, Inc. | 18 | $327 |
| LEO Pharma Inc. | 9 | $299 |
| Regeneron Healthcare Solutions, Inc. | 14 | $271 |
| Galderma Laboratories, L.P. | 14 | $240 |
| ABBVIE INC. | 14 | $235 |
| Novartis Pharmaceuticals Corporation | 10 | $224 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $102 |
| Incyte Corporation | 3 | $75 |
Products named: DUPIXENT, TREMFYA, Bimzelx, NEMLUVIO, ANZUPGO, RINVOQ, COSENTYX, ADBRY.
Industry payments across TX — which companies pay providers there.
